Fractal Therapeutics specializes in leveraging focused model-based analyses to quickly and efficiently advance drug discovery and development projects. We do this using parsimonious fit-for-purpose models based on preclinical and early-clinical data, that provide clear direction for experimental design and strategic decision-making, within very short timelines.

We are drug development scientists, skilled at using model-based approaches as a means to an end. Our team has spent many years working together in Big Pharma, learning what works and what doesn’t in model-based drug development.

Our scientists can work collaboratively with you to design optimal experiments that are focused narrowly on the critical path to the first-in-human trials, and to help you make the right design choices to advance your molecule quickly and cost-efficiently to the right decisions.